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SUMMARY
It has been suggested that a conservative trans-oral approach to proximal and hilo-parenchymal submandibular stones (HPSMS) is a valid 
alternative to the more frequently used sialadenectomy. The aim of this study was to evaluate the surgical, ultrasonographic and patients’ 
subjective outcomes of results of the trans-oral removal of HPSMS. Between January 2003 and September 2015, sialendoscope-assisted 
trans-oral surgery was used to remove symptomatic, large (> 7 mm), fixed and palpable HPSMS from 479 patients under general anaes-
thesia. All patients were followed clinically and ultrasonographically to investigate symptom relief and recurrence of stones, and were 
telephonically interviewed to assess saliva-related subjective outcomes with a questionnaire. Stones were successfully removed from 472 
patients (98.5%); the seven failures (1.5%) concerned pure parenchymal stones. One year after the procedure, 408 patients (85.1%) were 
symptom free, 59 (12.3%) had recurrent obstructive symptoms and 12 (2.6%) had recurrent infections. Of the 54 patients who developed a 
recurrent stone (11.2%), 52 underwent a second procedure: 29 interventional sialendoscopies, two sialendoscope-assisted intra-corporeal 
pneumatic lithotripsy, eight secondary transoral surgery to remove residual stones, six a cycle of extra-corporeal lithotripsy and seven sub-
mandibular sialadenectomy. Most patients (75.2%) reported mild surgery-related pain. The symptoms of 454 patients (94.8%) improved 
after adjunctive treatment and, at the end of follow-up, the affected gland was preserved in 98.5% of patients. A sialendoscope-assisted 
trans-oral removal of large HPSMS is a safe, effective, conservative surgical procedure, and functional preservation of the main duct and 
parenchyma of the obstructed gland allows sialendoscopic access through the natural ostium in case of recurrence. Combining a trans-oral 
approach with other minimally invasive, conservative procedures ensures symptomatic relief and salivary duct system clearance in the 
majority of patients.
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RIASSUNTO
Come si evince dall’analisi della letteratura, l’approccio transorale ai calcoli prossimali e ilo-parenchimali della ghiandola sottomandi-
bolare rappresenta una valida alternativa alla scialoadenectomia tradizionale. Lo scopo di questo studio è quello di valutare i risultati 
chirurgici, ecografici e soggettivi di questa tecnica conservativa. Tra Gennaio 2003 e Settembre 2015 sono stati trattati con l’approccio 
transorale scialoendoscopico-assistito 479 pazienti affetti da calcoli ilo-parenchimali sottomandibolari palpabili, non mobili, di dimensio-
ni superiori ai 7 mm. Tutti i pazienti sono stati sottoposti ad un follow-up clinico, ecografico e ad una valutazione soggettiva dell’outcome 
chirurgico per mezzo di un apposito questionario somministrato attraverso un’intervista telefonica.  Il successo chirurgico definito come 
completa asportazione del calcolo ilo-parenchimale è stato ottenuto in 472 pazienti (98.5%); in sette casi (1.5%) si è verificato un insuc-
cesso chirurgico, riguardante esclusivamente calcoli parenchimali puri. Un anno dopo l’intervento chirurgico, 408 pazienti (85.1%) non 
riferivano più sintomi ostruttivi, 59 pazienti (12.3%) riferivano sintomi ostruttivi ricorrenti e 12 (2.6%) infezioni ricorrenti. Dei 54 pazienti 
(11.2%) affetti da litiasi sottomandibolare ricorrente, 52 sono stati sottoposti ad una seconda procedura terapeutica, nello specifico in 29 
casi a scialoendoscopia, in 2 casi a litotrissia pneumatica intracorporea, in 8 casi a chirurgia transorale, in 6 casi ad un ciclo di litotrissia 
extracorporea, in 7 casi a scialoadenectomia sottomandibolare. La maggior parte dei pazienti (75.2%) ha riferito un dolore post-chirur-
gico di grado lieve. Al termine del follow-up, i sintomi riferiti da 454 pazienti (94.8%) erano migliorati dopo il secondo trattamento e la 
ghiandola sottomandibolare affetta era stata preservata nel 98.5% dei casi. La chirurgia transorale scialoendoscopico-assistita dei calcoli 
ilo-parenchimali della ghiandola sottomandibolare rappresenta un’opzione terapeutica sicura, efficace e conservativa e la preservazione 
del dotto e del parenchima ghiandolare permette di esplorare il sistema duttale attraverso l’ostio naturale in caso di ricorrenza della pa-
tologia. L’utilizzo combinato dell’approccio transorale e delle altre tecniche mini-invasive permette di trattare con successo la maggior 
parte dei pazienti affetti da litiasi ilo-parenchimale sottomandibolare.
PAROLE CHIAVE: Calcoli sottomandibolari • Chirurgia transorale • Scialoendoscopia • Scialoadenectomia sottomandibolare • Calcoli 
ilo-parenchimali
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Introduction
Sialolithiasis accounts for about 50% of benign obstruc-
tive salivary gland diseases 1, the annual symptomatic in-
cidence of which has recently been estimated to be 1/10-
30,000 subjects 2.
The submandibular glands (SMGs) are the most frequent-
ly affected (80-90%) 3 because of the narrow opening of 
Wharton’s duct, its ascendant course and length, and the 
mainly mucous composition of saliva 4, and the most fre-
quent locations of SMG stones are the distal tract of the 
duct and hilum (pure intraparenchymal stones account 
for  < 10%) 5. Typical symptoms are recurrent swelling 
and pain at mealtimes. In many cases, careful palpation 
of the oral floor allows the exact position of a stone to 
be detected, and diagnosis can be confirmed radiological-
ly by ultrasonography (US) 6, conventional radiography, 
computed tomography (CT) and/or cone beam tomogra-
phy (CBCT) 7.
Despite its known risks 8, sialadenectomy is still the most 
widely used procedure to treat proximal and HPSMS 9, 
but a conservative approach has emerged as a valid al-
ternative  10 11. It has been shown that trans-oral remov-
al of large (> 7 mm) and deeply located submandibular 
stones10  11, the spread of which has been favoured by the 
development of interventional sialendoscopy, is safe and 
effective 11, and highly successful in terms of stone remov-
al and symptom relief 6 11. A sialendoscope-assisted proce-
dure is useful because the brightness can help in detecting 
any residual intraparenchymal stones after removal of the 
main HPSMS 12, thus ensuring the complete clearance of 
the ductal system and eliminating symptoms of mealtime 
syndrome. On the basis of our previous findings 11, it can 
be expected that only a small percentage of patients expe-
rience (often asymptomatic) stone recurrence, especially 
those previously treated by extra-corporeal shock wave 
lithotripsy (ESWL) in whom the parenchymal spread of 
micro-debris may not be detected by US or during surgi-
cal exploration through the oral hilo-parenchymal open-
ing of the submandibular gland 13 14.
As a surgical procedure needs to be assessed on the basis 
of objective surgical and subjective patient perceived re-
sults measured using validated questionnaires 15, the aim 
of this study was to assess the surgical, US and subjec-
tive outcomes in a large series of patients who underwent 
trans-oral removal of a large HPSMS and who were fol-
lowed in the long term.
Materials and methods
Between January 2003 and September 2015, 479 patients 
(235 females) with a mean age of 46 years (range 19–81) 
underwent sialendoscope-assisted trans-oral surgical re-
moval of symptomatic, large (> 7 mm), fixed and palpable 
HPSMS at the Department of Otolaryngology and Head 
and Neck Surgery of Fondazione IRCCS Ca’ Granda 
Policlinico in Milan, 14 of whom had been previously and 
unsuccessfully treated by ESWL. All patients underwent 
US and Doppler US assessments (Hitachi H21, 7.5 MHz, 
Hitachi High Technology Corporation Ltd., Tokyo, Japan) 
and clinical evaluation to establish the size of the stone 
(minimum diameter 7 mm) and its location, which was 
clinically defined as hilar when at least two margins were 
detectable during bimanual palpation of the oral floor, 
hilo-parenchymal when only the distal margin was de-
tectable during palpation and the remaining margins were 
covered by glandular tissue, and intra-parenchymal when 
completely covered by glandular tissue 20. Exclusion cri-
teria were an inability to open the mouth sufficiently and 
presence of non-palpable stones.
Surgical procedure
The procedure was performed under general anaesthesia 
with headlight illumination and loupe magnification. With 
the mouth held open by a small gag, the tongue was re-
tracted antero-medially, and the floor of the mouth was 
infiltrated by 5 mL of mepivacaine 25 mg/mL + adren-
aline 5 mg/mL just below the oral mucosa. The duct was 
identified and cannulated using a salivary probe (Bowman 
probes, Karl Storz, Tuttlingen, Germany). An oblique in-
cision was made near the papillary region of Wharton’s 
duct, along the floor of the mouth toward the second mo-
lar. Once the mucosa was parted, the loose areolar tissue 
was dissected (first by means of sharp-tipped, and then 
with smooth-tipped scissors) medially to the internal edge 
of the sublingual gland, which was rotated laterally to ex-
pose Wharton’s duct. The horseshoe-shaped lingual nerve 
is easily identified running obliquely from the tongue, 
passing under the duct, and then ascending medially 
through the tail of the sublingual gland over Wharton’s 
duct to run below the constrictor muscles to the infra-tem-
poral fossa. The lingual nerve was mobilised from the 
duct and retracted medially to visualise the stone in the 
gland hilum, which was moved upward to the subman-
dibular gland area by external finger pressure. An incision 
was made over the calculus, and the stone was delivered 
using a micro- or Freer elevator (Martin, Tuttlingen, Ger-
many); submandibulotomy was performed in the case of 
intraparenchymal stones (Fig. 1). The cavity was then ir-
rigated with saline to clear any debris and a haemostatic 
and anti-microbial fibrillar surgical net (Tabotamp, John-
son & Johnson Medical Limited, Gargrave, Skipton, UK) 
was positioned over the hilar opening to avoid the risk 
of stricture or stenosis. Finally, the wound was irrigated 
with antibiotic solution (rifampicin), and the oral floor 
was sutured using resorbable stitches (3.0 Vicryl). In the 
case of ostial stenosis, the distal third of the duct can be 
rehabilitated by making an axial incision and inserting a 
6F polymeric salivary stent (Optimed, Ettlingen, Germa-
ny) or a 14-20 G Venflon tube (Artsana, Grandate, Italy) 
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attached to the oral floor with a resorbable suture, which 
are usually removed after two weeks.
Sialendoscopy (0.8-1.1 mm, Erlangen sialoendoscopes, 
Karl Storz Co., GmbH, Tuttlingen, Germany) is used 
to better locate the stone in the hilo-parenchymal, or to 
check for any residual intra-parenchymal stones or debris 
through the incision.
All patients received antibiotic therapy (amoxicillin and 
clavulanic acid) for one week after the procedure; steroids 
were also administered in the case of oral floor oedema.
Post-operative follow-up
Patients were clinically re-examined after one week, one 
month and one year to evaluate the course of wound heal-
ing and recovery of clear secretory flow from the papilla 
after gland massage, and any early or late post-operative 
complications were assessed. They were also offered US 
examination one year after the procedure to check the 
echogenicity of the glandular parenchyma and ascertain 
any ductal system dilation or residual stones.
All patients were telephoned to ask for saliva-related sub-
jective outcomes using a questionnaire created to measure 
trans-oral surgical outcomes on the basis of the proposal of 
Gillespie et al. 15 They were asked to describe any improve-
ment in symptoms and to grade surgery-related pain with a 
0-10 visual analogue scale (VAS, in which 0 = no pain, and 
10 = maximum pain). In the case of residual symptoms, the 
patients were asked about any further treatments (antibiotics 
or surgery) and grade the average pain felt using the same 
scale. Finally, they were asked if they would repeat and rec-
ommend trans-oral surgery to other patients.
Results
The US-measured size of stones ranged from seven to 26 
mm (mean 10, median 9 mm). The stones were located in 
the right SMG in 223 patients (46.5%), the left SMG in 
244 patients (51%), and bilaterally in 12 patients (2.5%); 
233 patients (48.7%) had hilar stones, 188 (39.3%) hilo-
parenchymal stones and 58 (12%) intra-parenchymal 
stones. The stones were successfully removed from 472 
patients (98.5%); the seven failures (1.5%) concerned pure 
parenchymal stones that could not be detached from the 
gland tissue despite the parenchymal incision (Table  I). 
Only 44 patients (9.2%) underwent a sialendoscope-
assisted procedure to locate an intra-parenchymal stone 
more precisely through the papillary ostium, (n = 18) or 
check for any residual parenchymal stones through the 
hilar opening (n = 26). No intra-operative complications 
were encountered.
Early sequelae were observed in 365 patients (76.1%) 
(Table II). These consisted of transient gland swelling 
(n  =  125), variable swelling and oedema of the mouth 
floor (n = 122), tingling of the tip of the tongue (n = 108) 
Fig. 1. Release of a hilo-parenchymal submandibular stone during sialendoscope-assisted transoral surgery.
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and transient lingual nerve injury (n = 10). Only 27 pa-
tients (5.6%) experienced late complications: persistent 
tingling of the tip of the tongue (n  =  3) and recurrent 
sialadenitis due to partial hilar stenoses revealed by US 
(n = 24). None of the patients experienced permanent lin-
gual nerve injury.
All patients were clinically followed at one and 12 months 
after the surgical procedure: 408 (85.1%) were symptom 
free, 59 (12.3%) had recurrent obstructive symptoms 
and 12 (2.6%) had recurrent infections. US examination 
at one year showed that parenchymal echogenicity and 
vascularisation had normalised in most patients, but 54 
(11.2%) had developed a subsequent stone (diameter 2-6 
mm). The size of the gland was normal in 32 patients, 
increased in 13 and decreased in 9 patients; no ductal dila-
tion was observed in 40 patients, whereas six showed mild 
hilar dilation and eight dilation within the ductal system.
Of the 71 patients with recurrent obstructive symptoms or 
infections, 29 underwent secondary interventional sialen-
doscopy, two sialendoscopy-assisted pneumatic intracor-
poreal lithotripsy; eight a secondary trans-oral procedure 
to remove residual stones, six a cycle of extra-corporeal 
lithotripsy, and seven submandibular sialadenectomy. The 
remaining 19 did not undergo any further procedure.
Trans-oral surgery led to resolution of symptoms (defined 
as the absence of any residual episodes of painful sali-
vary gland swelling) in 408 patients (85.1%) (Table III). 
Most patients (75.2%) reported mild surgery-related pain 
(VAS scores 1-5), but 24.8% experienced moderate pain 
(VAS scores 6-10); during the course of follow-up, 71 pa-
tients (14.9%) experienced recurrent swelling and moder-
ate pain, with 29 (40.5%) recording a mean VAS score of 
8: further treatments consisted of medical therapy alone 
in 25 patients (35.2%), and repeat surgery in 46 (64.8%). 
Symptoms improved after adjunctive treatment in 454 pa-
tients (94.8%) and, at the end of follow-up, the affected 
gland was intact in 98.5% of cases. The vast majority of 
patients (99.6%) said they would repeat and recommend 
sialendoscope-assisted trans-oral treatment.
Discussion
A trans-oral approach has recently been proposed as a 
gland-preserving alternative to sialadenectomy for deep 
and parenchymal stones 4 6. The main limitations of pre-
viously published studies are that many also included 
stones located in the main submandibular duct, very few 
describe long-term surgical results and none considered 
patients’ subjective perceptions or QoL factors. A further 
curiosity is that a combined sialendoscopy and trans-oral 
procedure has been advocated, although it is difficult to 
understand how sialendoscopy can influence the result of 
trans-oral stone removal.
We describe the objective and subjective outcomes of 
conservative sialendoscopy-assisted transoral surgery for 
Table I. Demographic and clinical characteristics of patients undergoing 
the sialendoscope-assisted trans-oral surgical removal of hilo-parenchymal 
stones.
  n %
Gender    
Male 244 50.9
Female 235 49.1
Previous treatments    
None 465 97.1
Shock wave lithotripsy 14 2.9
Side    
Right 223 46.5
Left 244 51
Bilateral 12 2.5
Site    
Hilar 233 48.7
Hilo-parenchymal 188 39.3
Intraparenchymal 58 12
Intra-operative complications    
Yes 0 0
No 479 100
Surgical results    
Success 472 98.5
Failure 7 1.5
Table II. Follow-up of patients undergoing conservative transoral surgery.
Early sequelae n  % 
None 114 23.9
Swelling only 125 26.1
Swelling and oedema 122 25.4
Tingling 108 22.5
Lingual nerve injury (transient) 10 2.1
Late complications    
None 452 94.4
Oral mycosis 0 0
Tingling 3 0.6
Ranula 0 0
Hilar stenosis 24 5
Lingual nerve injury (persistent) 0 0
Follow-up results    
No residual stones at US 425 88.7
Residual stones at US 54 11.3
Subjective evaluation    
No symptoms 408 85.1
Recurrent obstructive symptoms 59 12.3
Recurrent infections 12 2.6
Post-surgery treatments    
Interventional sialendoscopy 31 43.7
Other transoral removal 8 11.3
Sialoadenectomy 7 9.8
ESWL 6 8.6
None 19 26.6
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large, palpable submandibular stones in a large series of 
479 patients. The stones, which were all clinically and 
ultrasonographically classified as intra-parenchymal, 
were successfully retrieved from all but seven patients, in 
whom the failure was due to the fact that the stone could 
not be separated from the gland tissue despite the use of 
dedicated elevators. This good result is in line with our 
initial experience 1 and what has been reported by other 
authors 4 6 16, and demonstrate that the procedure is ef-
fective in removing deep submandibular stones. Most of 
these can be removed without using a sialendoscope but, 
in 9% of cases, the bright guidance of the sialendoscopic 
unit facilitated the search for residual parenchymal micro-
liths that had cracked during removal of the main stone or 
migrated backwards to the peri-hilar region.
On the basis of our data, the technique can be considered 
safe as only a small number of patients experienced what 
were only mild untoward effects, such as tingling of the 
tip of the tongue or the persistence of recurrent sialadeni-
tis due to a US-revealed hilar stenosis.
During follow-up, 85.1% of patients were considered 
asymptomatic although US allowed the discovery of a 
number of residual stones in 11.2% of them, 52 of whom 
were able to undergo a secondary procedure that was 
made possible by preservation of the entire ductal sys-
tem. Thirty-one underwent interventional sialendoscopy 
(including two who underwent sialendoscope-assisted 
pneumatic intracorporeal lithotripsy); eight underwent a 
second trans-oral procedure to remove residual stones; 
and six underwent a cycle of extra-corporeal lithotripsy. 
Traditional sialadenectomy was required in only seven 
patients with undetachable parenchymal stones; as fail-
ure is a possible event in the case of deep intra-glandular 
stones, informed double consent to concomitant sialad-
enectomy should be considered before surgery.
We have previously found 12 that recurrences mainly occur 
in the first 12 post-procedural months due to the persis-
tence of micro-debris in the gland parenchyma that can-
not be detected by US, something that is more frequent-
ly observed in patients who have previously undergone 
shock wave lithotripsy 17 18. Consequently, extra-corporeal 
lithotripsy should be used in combination with trans-oral 
surgery only as salvage therapy after surgery and not be-
fore. A new intra-corporeal lithotripter was successfully 
used in our patients with residual fragments after surgery. 
This new technique, which has recently been described by 
Koch et al. 19, seems to work well and may well become 
an alternative to trans-oral surgery in selected patients in 
the future. Multiple microliths are frequently encountered 
near the main stone during diagnostic work-up, but cannot 
be visualised by US even by an experienced radiologist. 
The risk of undiagnosed stones that may otherwise be left 
in the salivary duct system during surgery (especially in 
the case of a secondary approach) could possibly be re-
duced by combining US and cone beam 3D CT, as is cur-
rently done in the case of many ENT disorders 20.
Post-operative US showed that the ductal and parenchy-
mal characteristics of most patients normalised which, 
together with the significant reduction in the number of 
episodes of sialadenitis and the subjective perceptions re-
ported by patients, confirms that obstructive sialadenitis 
is reversible 17.
Conclusions
Sialendoscope-assisted trans-oral removal of large 
(>  7  mm) hilo-parenchymal submandibular stones is a 
Table III. Patient’s subjective findings after surgery for hilo-parenchymal 
submandibular stones.
n %
Symptoms resolved after first treatment 408 85.1
Pain secondary to trans-oral surgery (1-10)
1 3 0.6
2 56 11.8
3 75 15.7
4 114 23.7
5 112 23.4
6 63 13.2
7 44 9.1
8 12 2.5
9 0 0
10 0 0
Residual symptoms - recurrent swelling and 
pain (5-10)
71 14.9
5 5 7.6
6 17 24.1
7 18 25.3
8 29 40.5
9 2 2.5
10 0 0
Further treatment required 71 14.9
Antibiotics 25 35.2
Surgery 46 64.8
Improved symptoms after multiple treatments
Yes 454 94.8
No 25 5.2
Intact gland
Yes 472 98.5
No 7 1.5
Would repeat treatment
Yes 477 99.6
No 2 0.4
Would recommend treatment
Yes 477 99.6
No 2 0.4
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safe and effective conservative surgical procedure. It pre-
serves the main submandibular duct and allows the stone 
to be removed through a minimal incision in the hilo-pa-
renchymal region, thus ensuring functional preservation 
of the obstructed gland and allowing sialendoscopic ac-
cess through the natural ostium in the case of recurrence. 
At the same time, a multimodal approach combining all 
minimally invasive and conservative procedures (such as 
extra- and intra-corporeal lithotripsy and interventional 
sialendoscopy) can be planned to provide symptomatic 
relief and clearance of the salivary duct system. Pre-op-
erative clinical and US evaluation is always advisable to 
locate the stone precisely and minimise the risk of failure, 
especially in the case of pure intra-parenchymal stones. 
Particular attention should be paid to initial experiences 
with the newly available system of sialendoscope-assist-
ed pneumatic lithotripsy as this will probably reduce the 
number of patients undergoing trans-oral surgery for large 
stones. Although it cannot be defined as minimally inva-
sive, most patients would be prepared to repeat the proce-
dure and recommend it to others as it avoids the risks of 
traditional invasive external surgery.
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